Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.61 +0.15 (+4.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Galmed Pharmaceuticals (EOCN) Return on Sales [ROS] (2016 - 2019)

Updated

Galmed Pharmaceuticals' Return on Sales [ROS] came in at 797.85% for Q2 2019, down 163.26 percentage points from 961.11% a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Return on Sales [ROS] (2016 - 2019) Analysis & Trends

For FY2018, Galmed Pharmaceuticals' Return on Sales [ROS] was 525.76%, down 613.78 percentage points from FY2017.

  • Going back by year, Return on Sales [ROS] was 1139.54% in FY2017 (-2475.45 pp) and 3614.99% in FY2016.
  • The five-year range for quarterly Return on Sales [ROS] is 78.67% (Q3 2018) to 1971.50% (Q3 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Galmed Pharmaceuticals 420,034.32 420,034.32 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 797.85%
Dec 31, 2018 516.93%
Sep 30, 2018 78.67%
Jun 30, 2018 961.11%
Mar 31, 2018 954.85%
Dec 31, 2017 1,329.93%
Sep 30, 2017 1,009.16%
Jun 30, 2017 993.70%
Mar 31, 2017 1,217.91%
Dec 31, 2016 1,734.67%
Sep 30, 2016 1,971.50%
API Access

Galmed Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EOCN&period=max&api_key=YOUR_API_KEY